Delivery Order SPE2DX22D0010-SPE2D826FCR06
- Not listed
- On January 19, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $15,972.77 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. This firm fixed-price delivery order, with an ultimate completion date of January 20, 2026, was awarded on a non-set-aside, competitive basis. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under...
- On January 19, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $20,895.86 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. This firm fixed-price delivery order, with an ultimate completion date of January 20, 2026, represents a competitively awarded contract with no set-aside designation. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $150,760.44 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. (UEI: NWEGNLYTBDW4). This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by January 13, 2026, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award...
- On January 7, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,295.84 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This firm fixed-price, non-set-aside delivery order is scheduled for completion by January 8, 2026, with performance taking place at the awardee's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order issued under a larger indefinite delivery...
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $23,665.95 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This firm fixed-price delivery order, with an ultimate completion date of January 13, 2026, was competitively awarded with no set-aside designation. The contract is performed out of the contractor's corporate office location in Conshohocken, Pennsylvania, and represents a task order...
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,584.40 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. The contract, designated as a firm fixed-price delivery order with no set-aside designation, is scheduled for completion by January 13, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded and represents a routine...
- On January 19, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,314.12 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. This firm fixed-price, non-set-aside delivery order is scheduled for completion by January 20, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order issued under AmerSourceBergen's substantial Indefinite Delivery Contract...
- On January 22, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a $311,438.40 firm fixed-price delivery order to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. This non-set-aside, competitively awarded contract is scheduled for completion by January 23, 2026, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a task order issued under the broader pharmaceutical supply relationship...
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $381,227.84 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. This firm fixed-price delivery order, with an ultimate completion date of January 13, 2026, was competitively awarded without any set-aside designation. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task...
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,130.75 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of January 13, 2026 and involves no set-aside designation. The contract is performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCR06Delivery Order
On January 22, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,976.11 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. This firm fixed-price delivery order, which is scheduled for completion by January 23, 2026, was awarded on a competitive basis with no set-aside designation. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under a larger contract vehicle supporting the Defense Logistics Agency's pharmaceutical and medical supply procurement operations. AmerSourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The parent company, Cencora, Inc., maintains an even larger IDC with DLA valued up to $999,999,999.00 through December 31, 2031, underscoring the contractor's substantial role in the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 1/21/26 |